HK1198586A1 - -二氟甲基- -二氫- 噁嗪- -胺衍生物 - Google Patents

-二氟甲基- -二氫- 噁嗪- -胺衍生物

Info

Publication number
HK1198586A1
HK1198586A1 HK14112072A HK14112072A HK1198586A1 HK 1198586 A1 HK1198586 A1 HK 1198586A1 HK 14112072 A HK14112072 A HK 14112072A HK 14112072 A HK14112072 A HK 14112072A HK 1198586 A1 HK1198586 A1 HK 1198586A1
Authority
HK
Hong Kong
Prior art keywords
oxazin
difluoromethyl
dihydro
amine derivatives
amine
Prior art date
Application number
HK14112072A
Other languages
English (en)
Inventor
Andrs Avelino Trabanco-Surez
Henricus Jacobus Maria Gijsen
Michel Surkyn
Hana Prokopcov
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1198586A1 publication Critical patent/HK1198586A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
HK14112072A 2011-12-05 2014-12-01 -二氟甲基- -二氫- 噁嗪- -胺衍生物 HK1198586A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191997 2011-12-05
PCT/EP2012/074351 WO2013083557A1 (en) 2011-12-05 2012-12-04 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives

Publications (1)

Publication Number Publication Date
HK1198586A1 true HK1198586A1 (zh) 2015-04-30

Family

ID=47278317

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112072A HK1198586A1 (zh) 2011-12-05 2014-12-01 -二氟甲基- -二氫- 噁嗪- -胺衍生物

Country Status (19)

Country Link
US (1) US20140343048A1 (zh)
EP (1) EP2788346B1 (zh)
JP (1) JP6169095B2 (zh)
KR (1) KR102060379B1 (zh)
CN (1) CN103974951B (zh)
AU (1) AU2012347397B2 (zh)
BR (1) BR112014013310A2 (zh)
CA (1) CA2852366C (zh)
EA (1) EA023909B1 (zh)
ES (1) ES2558604T3 (zh)
HK (1) HK1198586A1 (zh)
IL (1) IL232916A (zh)
MX (1) MX357384B (zh)
MY (1) MY165209A (zh)
PH (1) PH12014501235A1 (zh)
SG (1) SG11201402734XA (zh)
UA (1) UA111749C2 (zh)
WO (1) WO2013083557A1 (zh)
ZA (1) ZA201404074B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102119161B (zh) 2008-06-13 2015-07-08 盐野义制药株式会社 具有β分泌酶抑制作用的含硫杂环衍生物
JPWO2011071135A1 (ja) 2009-12-11 2013-04-22 塩野義製薬株式会社 オキサジン誘導体
CN102933564B (zh) 2010-06-09 2015-07-22 詹森药业有限公司 用作β-分泌酶(BACE)抑制剂的5,6-二氢-2H-[1,4]噁嗪-3-基-胺衍生物
EP2655376B1 (en) 2010-12-22 2017-08-23 Janssen Pharmaceutica NV 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
KR102012675B1 (ko) 2011-03-09 2019-08-21 얀센 파마슈티카 엔.브이. 베타-세크레타제(BACE)의 억제제로서 유용한 3,4-디하이드로-피롤로[1,2-a]피라진-1-일아민 유도체
EP2788335B1 (en) * 2011-12-06 2016-04-13 Janssen Pharmaceutica, N.V. 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives for the treatment of disorders in which beta-secretase is involved
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
ES2697684T3 (es) 2013-06-12 2019-01-25 Janssen Pharmaceutica Nv Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5 a]pirazina como inhibidores de beta-secretasa (BACE)
AU2014280122B2 (en) 2013-06-12 2017-12-21 Janssen Pharmaceutica Nv 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)
CA2911693C (en) 2013-06-12 2021-08-24 Janssen Pharmaceutica Nv 4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (bace)
AU2015367594C1 (en) 2014-12-18 2019-10-31 Janssen Pharmaceutica Nv 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
US20230074641A1 (en) * 2020-01-27 2023-03-09 Silcotek Corp. Biopharmaceutical manufacturing process and product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077328A1 (es) 2009-07-24 2011-08-17 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos
US8188079B2 (en) * 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
CN102933564B (zh) 2010-06-09 2015-07-22 詹森药业有限公司 用作β-分泌酶(BACE)抑制剂的5,6-二氢-2H-[1,4]噁嗪-3-基-胺衍生物
BR112013017779A2 (pt) * 2011-01-12 2016-10-11 Novartis Ag derivados de oxazina e seu uso no tratamento de distúrbios neurológicos
JP2012147763A (ja) * 2011-01-17 2012-08-09 Toshitaka Kobayashi 乾物穿孔具
EP2788335B1 (en) * 2011-12-06 2016-04-13 Janssen Pharmaceutica, N.V. 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives for the treatment of disorders in which beta-secretase is involved

Also Published As

Publication number Publication date
IL232916A (en) 2016-07-31
BR112014013310A2 (pt) 2017-06-13
PH12014501235B1 (en) 2014-09-08
ES2558604T3 (es) 2016-02-05
EP2788346B1 (en) 2015-10-28
AU2012347397B2 (en) 2016-09-22
NZ626662A (en) 2015-05-29
IL232916A0 (en) 2014-08-03
ZA201404074B (en) 2016-10-26
UA111749C2 (uk) 2016-06-10
KR20140107209A (ko) 2014-09-04
CN103974951B (zh) 2016-04-13
CN103974951A (zh) 2014-08-06
CA2852366C (en) 2020-02-18
MY165209A (en) 2018-03-05
MX2014006689A (es) 2014-09-04
JP6169095B2 (ja) 2017-07-26
US20140343048A1 (en) 2014-11-20
PH12014501235A1 (en) 2014-09-08
SG11201402734XA (en) 2014-06-27
EA023909B1 (ru) 2016-07-29
EA201491116A1 (ru) 2014-12-30
KR102060379B1 (ko) 2019-12-30
WO2013083557A1 (en) 2013-06-13
MX357384B (es) 2018-07-06
EP2788346A1 (en) 2014-10-15
JP2015500223A (ja) 2015-01-05
CA2852366A1 (en) 2013-06-13
AU2012347397A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
SG10201601802YA (en) Dispiropyrrolidine derivatives
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
ZA201401884B (en) New dihydroquinoline-2-one derivatives
IL247640A0 (en) History of heteroaryl piperidine
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
HK1198535A1 (zh) -氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物
IL231950B (en) Aryl-quinoline derivatives
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
EP2721029A4 (en) IMIDAZOPYRIDIN-2-ONE DERIVATIVES
EP2671878A4 (en) SUBSTITUTED N-PENTANAMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
MY165626A (en) 1,2,4,-triazolone derivative
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
HK1191942A1 (zh) 新型六氫環戊二烯並吡咯酮,六氫吡咯並吡咯酮,八氫吡咯並吡啶酮和八氫吡啶酮化合物
IL232630A0 (en) A method for the preparation of 6,2-difluoroacetophenones
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201210